BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33229463)

  • 1. Successful countering of tobacco industry efforts to overturn Thailand's ENDS ban.
    Patanavanich R; Glantz S
    Tob Control; 2021 Nov; 30(e1):e10-e19. PubMed ID: 33229463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand.
    Patanavanich R; Glantz SA
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame.
    Charoenca N; Kungskulniti N; Hamann S; Mock J
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building tobacco control research in Thailand: meeting the need for innovative change in Asia.
    Hamann SL; Mock J; Hense S; Charoenca N; Kungskulniti N
    Health Res Policy Syst; 2012 Jan; 10():3. PubMed ID: 22284811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance to Online Retail of Electronic Nicotine Delivery Systems (ENDS) in India before and after the 2018 Ban Order of the Government of India.
    Lal P; Kapoor R; Singh RJ
    Asian Pac J Cancer Prev; 2021 Nov; 22(S2):13-17. PubMed ID: 34780134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco control in Nepal during a time of government turmoil (1960-2006).
    Bhatta D; Crosbie E; Bialous S; Glantz S
    Tob Control; 2020 Sep; 29(5):548-555. PubMed ID: 31363061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International.
    Levy DT; Warner KE; Liber AC; Travis N; Sweanor DT; Meza R; Cummings KM
    Nicotine Tob Res; 2023 Nov; 25(12):1899-1903. PubMed ID: 37535864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Analysis of Arguments Advanced via Twitter in an Advocacy Campaign to Promote Electronic Nicotine Delivery Systems.
    Lee E; Hoek J; Fenton E; Joshi A; Evans-Reeves K; Robertson L
    Nicotine Tob Res; 2023 Feb; 25(3):533-540. PubMed ID: 36269978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International expert consensus on electronic nicotine delivery systems and heated tobacco products: a Delphi survey.
    Berlin I; Jacot-Sadowski I; Humair JP; Cornuz J
    BMJ Open; 2021 Sep; 11(9):e045724. PubMed ID: 34493505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
    Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
    Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
    Lempert LK; Bialous S; Glantz S
    Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues raised by a ban on the sale of electronic nicotine devices.
    Hall W; Gartner C; Forlini C
    Addiction; 2015 Jul; 110(7):1061-7. PubMed ID: 25845485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heated debates on regulations of heated tobacco products in South Korea: the news valence, source and framing of relative risk/benefit.
    Jun J; Kim SH; Thrasher J; Cho YJ; Heo YJ
    Tob Control; 2022 Aug; 31(e1):e57-e63. PubMed ID: 33542068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.
    Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL
    Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tobacco and nicotine products in Latin America and the Caribbean: assessing the market and regulatory environment.
    Crosbie E; Severini G; Beem A; Tran B; Sebrie EM
    Tob Control; 2023 Jul; 32(4):458-466. PubMed ID: 34916305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workplace smoke-free policies that allow heated tobacco products and electronic cigarettes use are associated with use of both these products and conventional tobacco smoking: the 2018 JASTIS study.
    Siripongvutikorn Y; Tabuchi T; Okawa S
    Tob Control; 2021 Mar; 30(2):147-154. PubMed ID: 32188769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Twitter activity around the eighth meeting of the Conference of the Parties to the WHO Framework Convention on Tobacco Control.
    Robertson L; Joshi A; Legg T; Wellock G; Ray K; Evans-Reeves K
    Tob Control; 2022 Jan; 31(1):50-56. PubMed ID: 33177210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IQOS introduction on Philip Morris International cigarette sales in Spain: a Logarithmic Mean Divisa Index decomposition approach.
    Golpe AA; Martín-Álvarez JM; Galiano A; Asensio E
    Gac Sanit; 2022; 36(4):293-300. PubMed ID: 35219532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.